BRADENTON, Fla., June 08, 2026 (GLOBE NEWSWIRE) -- First Watch Restaurant Group, Inc. (Nasdaq: FWRG) (“First Watch” or the “Company”), the leading Daytime Dining concept serving breakfast, brunch and lunch, today announced the appointment of Ashlee Weisser to Chief Financial Officer effective June 8, 2026. She succeeds Mel Hope, who announced his planned retirement earlier this year and will continue to serve in an Advisor role to support a seamless leadership transition.
SOLON, Ohio, June 8, 2026 /PRNewswire/ -- From ancient etchings to contemporary icons, human beings have always had an enduring instinct to communicate through...
NEW YORK, June 8, 2026 /PRNewswire/ -- The All Stars Project, Inc. (ASP) announced the launch of its new Artistic Advisory Council (Council), composed...
Increased AI deployment results in an aggregated net hiring effect of +27% expected in 2026, while upskilling internal talent emerges as the primary strategy...
TIANJIN, China, June 08, 2026 (GLOBE NEWSWIRE) -- Ekspo Industri Perkapalan Antarabangsa Tianjin (TISIE) Ke-4 yang dibuka di Perbandaran Tianjin, utara China pada 2 Jun, telah dianjurkan oleh Zhenwei International Exhibition Group, sekali gus memamerkan peluang AI yang kian berkembang dalam industri perkapalan.
Ingelheim, Germany - Boehringer Ingelheim today announced positive results from two global Phase III trials of its glucagon/GLP-1 dual agonist survodutide (BI 456906), SYNCHRONIZE-1 and SYNCHRONIZE-MASLD.2,4 The results demonstrate survodutide’s potential to reduce weight and therefore improve metabolic health in two distinct populations: adults living with obesity or overweight, without type 2 diabetes (SYNCHRONIZE-1),2 and adults with overweight or obesity with metabolic dysfunction-associated steatotic liver disease (MASLD) with evidence of inflammation and or fibrosis (SYNCHRONIZE-MASLD).4 Full results from SYNCHRONIZE-1 and SYNCHRONIZE-MASLD were presented today at the American Diabetes Association’s (ADA) 2026 Scientific Sessions and published simultaneously in The New England Journal of Medicine and Nature Medicine respectively.5,6